Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 12-2019 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,704 | -23,802 | -24,430 | -500,790 | -369,160 |
| Depreciation Amortization | 39 | 37 | 2,440 | 76,510 | 69,920 |
| Accounts payable and accrued liabilities | 1,796 | N/A | N/A | N/A | N/A |
| Other Working Capital | 3,442 | 7,549 | -14,950 | -21,750 | -40,550 |
| Other Operating Activity | 2,807 | 1,272 | 39,180 | 329,110 | 288,670 |
| Operating Cash Flow | $-6,620 | $-14,944 | $2,240 | $-116,920 | $-51,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -95 | -426 | -2,740 | -15,980 | -10,820 |
| Net Acquisitions | N/A | 0 | 41,590 | -118,870 | 0 |
| Other Investing Activity | 0 | 0 | 13,350 | 166,890 | -10,710 |
| Investing Cash Flow | $-95 | $-426 | $52,200 | $32,040 | $-21,530 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,771 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 11,436 | -27,380 | 83,650 | 69,520 |
| Financing Cash Flow | $7,772 | $11,436 | $-27,380 | $83,650 | $69,520 |
| Exchange Rate Effect | -68 | -122 | 10 | -3 | -70 |
| Beginning Cash Position | 299 | 4,356 | 17,290 | 18,510 | 18,510 |
| End Cash Position | 1,287 | 299 | 44,360 | 17,290 | 15,310 |
| Net Cash Flow | $988 | $-4,057 | $27,070 | $-1,220 | $-3,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,620 | -14,944 | 2,240 | -116,920 | -51,120 |
| Capital Expenditure | -95 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -6,715 | -14,944 | 2,240 | -116,920 | -51,120 |